Stacy L ChinFounder, KeepYourEquity · I get the government to write you checks

ARPA-H: Revolutionizing Healthcare Innovation with NIH | Funding Opportunities!

20 Jun 2023 · 1 min

Watch on YouTube

0:55

In this video Stacy Chin introduces ARPA-H, a newly created U.S. federal agency modeled after DARPA that partners with the NIH to accelerate the development of high‑impact health innovations. She explains ARPA-H’s mission to improve health outcomes by supporting high‑risk, high‑reward solutions to the nation’s toughest health challenges. The agency seeks to fund startups and businesses developing breakthrough health technologies, offering non‑dilutive funding opportunities. Chin highlights that ARPA-H currently has open Broad Agency Announcements (BAAs) for specific project areas and notes that additional funding mechanisms such as SBIR contracts and grants will be opened in the future, encouraging viewers to explore whether they fit these programs.

Chapters

So have you guys heard about this brand new US federal agency called ARPA-H? So ARPA-H is following a similar style to DARPA, but it's actually partnering with the NIH to help bring new innovations and health technologies to the commercial market. And according to their website, ARPA-H's mission is to accelerate better health outcomes for everyone by supporting the development of high-impact solutions to society's most challenging health problems. So what does that mean? That means ARPA-H is interested in funding startups and businesses that are focused on developing high-impact and high-risk innovations that can benefit healthcare across the US. So what does that mean for you guys? That means there is a whole other pot of non-diluted funding opportunities that you guys should look into to see if you might be a good fit. So right now there are a couple of open BAAs, or Broad Agency Announcements, that ARPA-H has released of different projects they're interested in funding. And down the road, they're going to open more topics like SBIR contracts and grants and other non-diluted funding opportunities.